EXADOSE Trademark

Trademark Overview

On Tuesday, September 28, 2021, a trademark application was filed for EXADOSE with the United States Patent and Trademark Office. The USPTO has given the EXADOSE trademark a serial number of 79326349. The federal status of this trademark filing is REGISTERED as of Tuesday, December 13, 2022. This trademark is owned by NIPRO CORPORATION. The EXADOSE trademark is filed in the Medical Instrument Products category with the following description:

Nasal spray syringes sold empty
exadose

General Information

Serial Number79326349
Word MarkEXADOSE
Filing DateTuesday, September 28, 2021
Status700 - REGISTERED
Status DateTuesday, December 13, 2022
Registration Number6920307
Registration DateTuesday, December 13, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Pseudo MarkEXAM DOSE
Goods and ServicesNasal spray syringes sold empty

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, December 7, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNIPRO CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameNIPRO CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameNIPRO CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Monday, January 1, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 31, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 31, 2023FINAL DISPOSITION PROCESSED
Monday, March 13, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 13, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 19, 2022REFUSAL PROCESSED BY IB
Wednesday, June 29, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 29, 2022REFUSAL PROCESSED BY MPU
Wednesday, June 15, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 14, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 14, 2022ASSIGNED TO EXAMINER
Saturday, December 11, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, December 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 6, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 25, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

exadose empty sold syringes spray nasal